Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Exousia Bio (LMMY) EBIT Margin (2023 - 2024)

Lamy (LMMY) has disclosed EBIT Margin for 2 consecutive years, with 115.79% as the latest value for Q3 2024.

  • Quarterly EBIT Margin changed N/A to 115.79% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 211.84% through May 2025, down 3877.0% year-over-year, with the annual reading at 465.73% for FY2025, 31386.0% down from the prior year.
  • EBIT Margin hit 115.79% in Q3 2024 for Lamy, down from 289.04% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 289.04% in Q2 2024 to a low of 224.39% in Q1 2024.